STOCK TITAN

CNS interim CFO awarded 2,154 RSU-linked shares; total 26,018 held

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cohen & Steers, Inc. (CNS) insider transaction: The company’s Interim CFO and SVP reported an acquisition of 2,154 shares of common stock on 10/17/2025 at a reported price of $0, tied to a grant of restricted stock units (RSUs). Following the transaction, the reporting person beneficially owns 26,018 shares directly.

The RSUs vest ratably over four years. Any dividends paid on the common stock are paid as additional RSUs, and those dividend RSUs vest on the fourth anniversary of the original RSU grant date.

Positive

  • None.

Negative

  • None.
Insider Donohue Michael T.
Role Interim CFO, SVP
Type Security Shares Price Value
Grant/Award Common Stock 2,154 $0.00 --
Holdings After Transaction: Common Stock — 26,018 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Donohue Michael T.

(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS

(Street)
NEW YORK NY 10036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CFO, SVP
3. Date of Earliest Transaction (Month/Day/Year)
10/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/17/2025 A 2,154(1) A $0 26,018 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted by the issuer to the reporting person. Any dividends paid on the issuer's common stock are paid in additional RSUs (the "dividend RSUs"). The RSUs vest ratably over four years, and the dividend RSUs vest on the fourth anniversary of the grant date of the RSUs.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 10/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CNS disclose on this Form 4?

An insider acquisition of 2,154 shares of common stock linked to an RSU grant on 10/17/2025 at a reported price of $0.

How many CNS shares does the reporting person now own?

Beneficial ownership totals 26,018 shares held directly after the reported transaction.

What are the vesting terms of the RSUs reported by CNS?

The RSUs vest ratably over four years. Any dividend RSUs vest on the fourth anniversary of the original grant date.

Who is the reporting person in the CNS filing?

An Officer of the company serving as Interim CFO, SVP.

What was the transaction date in the CNS Form 4?

The earliest transaction date reported is 10/17/2025.

What type of security is involved in the CNS transaction?

Common stock, with the grant represented by restricted stock units (RSUs).

How are dividends treated for the CNS RSUs?

Dividends, if any, are paid in additional RSUs, which vest on the fourth anniversary of the original RSU grant date.